Colorcon starts No-Tox ink manufacturing at new UK facility

4 Feb 2020

The additional capacity will provide customers with shorter lead times and reduced transportation costs.

Colorcon No-Tox Products, a leader in the design and manufacture of FDA and EU regulatory compliant specialty printing inks for direct and indirect contact with food, medical devices and pharmaceutical products has opened a new UK-based manufacturing facility to serve its growing customer base in Europe, the Middle East and Africa (EMEA).

Colorcon starts No-Tox ink manufacturing at new UK facility

With this new manufacturing capacity, Colorcon No-Tox is strengthening its presence in the European and UK markets and will provide its customers with shorter lead times and reduced transportation costs.

“We are excited to announce this important next step in our strategy to become an integral part of our customers’ supply chains,” said Simon Tasker, President, Colorcon Americas.

“Our new No-Tox plant in the UK, which is an extension of our existing pharmaceutical manufacturing plant in Dartford will allow us to serve our customers in increasingly better and more efficient ways by providing our high-quality regulatory compliant inks and coatings with close proximity to their markets and at lower transportation costs.”

David Bain, Managing Director, Colorcon Ltd added: “Our regional team is looking forward to supporting this next stage in the strategic market expansion of our Colorcon No-Tox specialty printing ink business. The plant will initially focus on regulatory compliant inks and coatings for direct and indirect food contact applications; such as those widely used in the plastic to paper straw conversion. The addition of medical and pharmaceutical inks and coatings will be extended through 2020.”

Read More

Related news

Novartis receives EC Approval for next-gen anti-VEGF treatment for wet AMD

Novartis receives EC Approval for next-gen anti-VEGF treatment for wet AMD

21 Feb 2020

Beovu is the only anti-VEGF treatment approved in Europe for wet AMD that offers the option to start eligible patients on 3-month dosing intervals immediately after the loading phase.

Read more 
The game is on for connected devices

The game is on for connected devices

20 Feb 2020

Global biologics markets, delivery device innovation and smart packaging ‘unpacking’ new growth opportunities for pharma.

Read more 
Management healthcare consultancy opens new offices in New York and London

Management healthcare consultancy opens new offices in New York and London

19 Feb 2020

The expansion will enable Putnam Associates to access the European market and to offer more localised support to its clients.

Read more 
CPhI South East Asia rescheduled for July 2020

CPhI South East Asia rescheduled for July 2020

18 Feb 2020

Event move ensures extra precautions and safety measures taken

Read more 
Sphere Fluidics expands to increase supply of surfactant for droplet microfluidics

Sphere Fluidics expands to increase supply of surfactant for droplet microfluidics

18 Feb 2020

Investment in resources to meet demand for large-scale supply of patented biocompatible surfactant.

Read more 
Dr Reddy's to acquire Wockhardt divisions

Dr Reddy's to acquire Wockhardt divisions

18 Feb 2020

Deal sees 62 brands in multiple therapy areas and a manufacturing plant transfer to the company

Read more 
Sartorius sharpens its brand focus

Sartorius sharpens its brand focus

17 Feb 2020

The company aims to simplify its customers’ work and thus help them to achieve medical progress and make innovative medicines available faster.

Read more 
FDA success for MedPharm Centre of Excellence

FDA success for MedPharm Centre of Excellence

14 Feb 2020

The inspection was triggered by data generated by MedPharm as part of a client’s ANDA for a generic topical product.

Read more 
Report predicts booming ASEAN generics export market for 2020

Report predicts booming ASEAN generics export market for 2020

13 Feb 2020

The changing opportunities are attributed to rising GMP standards and increased regional harmonization.

Read more 
Partnership formed to deliver effective biopharma industry testing

Partnership formed to deliver effective biopharma industry testing

12 Feb 2020

Stevanato and Pfeiffer Vacuum will provide biopharma companies with advanced container closure integrity analysis and testing protocols.

Read more